Table 2. Flow cytometric analysis of BM... | American Society of Hematology

Table 2.

Flow cytometric analysis of BM cells

	Nonanemic RA patients (n = 10)	ACD RA patients (n = 11)	Total RA patients^* (n = 21)	Normal controls (n = 21)
% CD34⁺/CD71⁺cells	0.39 ± 0.29^†	0.26 ± 0.18	0.32 ± 0.24	0.60 ± 0.33
Median (range)	0.3 (0.1-1.1)	0.2 (0.1-0.6)	0.3 (0.1-1.1)	0.6 (0.1-1.4)
P^‡	.0398	.0014	.0011
P^2-153	.2169
% CD36⁺/glycoA⁺cells	22.18 ± 8.05	27.91 ± 6.66	25.28 ± 7.59	23.98 ± 6.35
Median (range)	23.2 (11.1-38.6)	28.3 (19.3-42.3)	23.7 (11.1-42.3)	23.5 (13.1-38.2)
P^‡	.4343	.1267	.6061
P^2-153	.0529
% CD36⁻/glycoA⁺cells	65.61 ± 9.60	58.43 ± 8.03	61.73 ± 9.16	66.77 ± 9.09
Median (range)	64.40 (46.5-78.5)	58.70 (42.0-71.2)	62.3 (42.0-78.5)	69.1 (43.9-78.8)
P^‡	.5541	.0125	.0483
P^2-153	.0378

	Nonanemic RA patients (n = 10)	ACD RA patients (n = 11)	Total RA patients^* (n = 21)	Normal controls (n = 21)
% CD34⁺/CD71⁺cells	0.39 ± 0.29^†	0.26 ± 0.18	0.32 ± 0.24	0.60 ± 0.33
Median (range)	0.3 (0.1-1.1)	0.2 (0.1-0.6)	0.3 (0.1-1.1)	0.6 (0.1-1.4)
P^‡	.0398	.0014	.0011
P^2-153	.2169
% CD36⁺/glycoA⁺cells	22.18 ± 8.05	27.91 ± 6.66	25.28 ± 7.59	23.98 ± 6.35
Median (range)	23.2 (11.1-38.6)	28.3 (19.3-42.3)	23.7 (11.1-42.3)	23.5 (13.1-38.2)
P^‡	.4343	.1267	.6061
P^2-153	.0529
% CD36⁻/glycoA⁺cells	65.61 ± 9.60	58.43 ± 8.03	61.73 ± 9.16	66.77 ± 9.09
Median (range)	64.40 (46.5-78.5)	58.70 (42.0-71.2)	62.3 (42.0-78.5)	69.1 (43.9-78.8)
P^‡	.5541	.0125	.0483
P^2-153	.0378

Comparison (

‡

) between patients in group and normal controls; (

F2-153

) between patients with ACD and nonanemic patients. Statistical analysis was performed using the nonparametric Mann-Whitney U test. P ≤ .05 was considered statistically significant.

Total RA patients includes nonanemic and ACD RA patients.

†

Values are expressed as mean ± 1 SD.

View Large

This Feature Is Available To Subscribers Only